FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * BIOGEN IDEC INC   2. Issuer Name and Ticker or Trading Symbol TARGETED GENETICS CORP /WA/ [TGEN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 14 CAMBRIDGE CENTER 3. Date of Earliest Transaction (Month/Day/Year) 07/25/2005 (Street) CAMBRIDGE, MA 02142 4. If Amendment, Date Original Filed(Month/Day/Year) 07/27/2005 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $0.01 Par Value 07/25/2005   S   8,500 D $ 0.79 11,966,948 (1) I by Biogen Idec MA, Inc. (2) Common Stock, $0.01 Par Value 07/26/2005   S   2,500 D $ 0.81 11,964,448 (1) I by Biogen Idec MA, Inc. (2) Common Stock, $0.01 Par Value 07/26/2005   S   12,500 D $ 0.82 11,951,948 (1) I by Biogen Idec MA, Inc. (2) Common Stock, $0.01 Par Value 07/26/2005   S   10,640 D $ 0.83 11,941,308 (1) I by Biogen Idec MA, Inc. (2) Common Stock, $0.01 Par Value 07/26/2005   S   11,200 D $ 0.85 11,930,108 (1) I by Biogen Idec MA, Inc. (2) Common Stock, $0.01 Par Value 07/26/2005   S   25,660 D $ 0.86 11,904,448 (1) I by Biogen Idec MA, Inc. (2) Common Stock, $0.01 Par Value 07/26/2005   S   2,500 D $ 0.87 11,901,948 (1) I by Biogen Idec MA, Inc. (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
BIOGEN IDEC INC 14 CAMBRIDGE CENTER CAMBRIDGE, MA 02142		X
BIOGEN IDEC MA INC 14 CAMBRIDGE CENTER CAMBRIDGE, MA 02142		X

Signatures

Raymond G. Arner, Acting General Counsel, Biogen Idec Inc.		07/29/2005
**Signature of Reporting Person		Date
Michael F. Phelps, Treasurer, Biogen Idec MA, Inc.		07/29/2005
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This amendment to the Form 4 originally filed on July 27, 2005 (the "Original Form 4") amends and restates the Original Form 4 in its entirety and is being filed solely to correct the amount of Targeted Genetics Corporation common stock beneficially owned by the reporting person. The Original Form 4 inadvertently overreported the reporting person's beneficial ownership of Targeted Genetics Corporation common stock by 25,000 shares.
(2)	Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.